<DOC>
	<DOCNO>NCT02430584</DOCNO>
	<brief_summary>To obtain whole blood specimen pregnant subject use research development clinical validation study prenatal assay .</brief_summary>
	<brief_title>Whole Blood Specimen Collection From Pregnant Subjects</brief_title>
	<detailed_description>This sample collection protocol allow identification , recruitment , participation woman pregnant know : 1. increase risk fetal genetic abnormality 2. increase risk congenital fetal infection virtue positive initial screening test , know active infection pregnancy . 3. possess irregular blood group antigens ( subject father baby ) therefore increase risk fetal sensitization pregnancy .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Down Syndrome</mesh_term>
	<mesh_term>Turner Syndrome</mesh_term>
	<mesh_term>Gonadal Dysgenesis</mesh_term>
	<mesh_term>Primary Ovarian Insufficiency</mesh_term>
	<mesh_term>Klinefelter Syndrome</mesh_term>
	<mesh_term>DiGeorge Syndrome</mesh_term>
	<criteria>Subject willing provide consent 50 mL whole blood collect one monthly ( â‰¥25 day ) clinic visit Subject pregnant carry singleton fetus 10 26 week gestational age inclusive Subject 18 year age old Subject increase risk one following : fetal gene chromosome abnormality congenital fetal infection know possess irregular blood group antigens ( subject father baby ) know condition amenable noninvasive prenatal test Pregnancy nonviable</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>